drugset / Trial / NCT03201601
Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the present study is to evaluate the effect of increasing the proportion of D-chiro-inositol (DCI) in a combination with myo-inositol (MYO) in improving fertility in women with polycystic ovarian syndrome (PCOS). Sixty women diagnosed with PCOS will randomly take twice a day for 12 weeks a capsule containing 550 mg of myo-inositol and 150 mg of D-chiro-inositol or capsules containing 550 mg of myo-inositol and 13.8 mg of D-chiro-inositol.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-05
- Completion
- 2017-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D-chiro-inositol | Small molecule | 13.8 mg | — |
| Subject | D-chiro-inositol | Small molecule | 150 mg | — |
| Subject | Inositol | Small molecule | 550 mg | — |